VIDEO

FindCenter AddIcon

What Ketamine Actually Does to Your Brain

2019

Ketamine, once known for its "club enhancing" effects, is now an FDA approved anti-depressant. Over four million Americans suffer from treatment-resistant depression. The new drug is a glimmer of hope for many.

04:35 min

43:07

Bob Jesse: “Entheogens, Awakening, and Spiritual Development” | Horizons 2009

Profound experiences of non-dual consciousness sometimes lead to lasting, and lastingly beneficial, changes in values and behavior.

FindCenter AddIcon
32:34

Can Ayahuasca Promote Peace in the Middle East? Conversations with Palestinians and Israelis

A collaboration between MAPS and the Centre for Psychedelic Research at Imperial College London, Antwan Saca, Leor Roseman, Ph.D., and Natalie Ginsberg, M.S.W.

FindCenter AddIcon
37:04

Rick Doblin & Natalie Ginsberg: Rescheduling MDMA - History, Present and Future

Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.

FindCenter AddIcon
58:39

MINDSET Lecture Series: Natalie Ginsberg, MSW

Natalie Ginsberg, MSW, discusses ayahuasca and the healing potential of psychedelics for intergenerational trauma in the Palestinian-Israeli conflict.

FindCenter AddIcon
01:51

The Importance of the Psychedelic Experience During Ketamine Infusions

Part of the way healing occurs during the ketamine infusion is due to the non-ordinary (psychedelic) experience. In this non-ordinary state, the unconscious mind is accessed and allows processing of unresolved emotions and traumatic events.

FindCenter AddIcon
52:36

The Science of Psychedelics with Michael Pollan

How could LSD and psilocybin help with mental health, palliative care and addictive behaviours? What was the point of a psilocybin mushroom evolving the way that it did? Michael Pollan explores the “second wave” of international research and discusses what psychedelic drugs may teach us about...

FindCenter AddIcon
17:18

Dr. Robin Carhart Harris: Psilocybin and the Psychedelic State

Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.

FindCenter AddIcon

EXPLORE TOPIC

Ketamine